Evidence map›Paper›PMID 21795541›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2011

α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief.

Tresa M McGranahan, Natalie E Patzlaff, Sharon R Grady, Stephen F Heinemann, T K Booker

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 4 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 4 syntheses or guidelines pooled it, 156 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2013
    Trial
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Precise mapping of a snake venom phospholipase AToxicon : official journal of the International Society on Toxinology · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Tresa M McGranahanSalk Institute for Biological Studies, La Jolla, California 92037, USA. tmcgranahan@ucsd.edu
Natalie E Patzlaff
Sharon R Grady
Stephen F Heinemann
T K Booker
Salk Institute for Biological Studies · USUniversity of Colorado Boulder · US

Funding

GENETICS OF NICOTINE TOLERANCE: ROLE OF RECEPTORSR01DA003194 · NIDA · UNIVERSITY OF COLORADO AT BOULDER · PI MARKS, MICHAEL J · 1985 to 2013
$5.5M
ALPHA-CONOTOXIN MII--SELECTIVE NICOTINIC RECEPTOR PROBER01DA012242 · NIDA · UNIVERSITY OF COLORADO AT BOULDER · PI WHITEAKER, PAUL · 1999 to 2011
$3.5M
Role of Nicotinic Receptors in Effects of AlcoholR01AA013018 · NIAAA · UNIVERSITY OF COLORADO AT BOULDER · PI WEHNER, JEANNE M · 2002 to 2006
$2.2M
Role of Brain Nicotinic Receptors in Addiction BehaviorsR01DA018247 · NIDA · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI HEINEMANN, STEPHEN FOX · 2006 to 2010
$1.8M
ESTABLISHING THE ROLE OF ALPHA-4 NICOTINIC RECEPTORSF32NS010830 · NINDS · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI BOOKER, TAMMY K · 1999 to 2000
$38k
NIAAA NIH HHS AA13018NIAAA NIH HHS R01 AA013018NIDA NIH HHS DA003194NIDA NIH HHS DA012242NIDA NIH HHS DA018247NIDA NIH HHS R01 DA003194NIDA NIH HHS R01 DA012242NIDA NIH HHS R01 DA018247NINDS NIH HHS F32 NS010830NINDS NIH HHS NS10830
6 · The paper itself

Abstract

Nicotine is the primary psychoactive substance in tobacco, and it exerts its effects by interaction with various subtypes of nicotinic acetylcholine receptors (nAChRs) in the brain. One of the major subtypes expressed in brain, the α4β2-nAChR, endogenously modulates neuronal excitability and thereby, modifies certain normal as well as nicotine-induced behaviors. Although α4-containing nAChRs are widely expressed across the brain, a major focus has been on their roles within midbrain dopaminergic regions involved in drug addiction, mental illness, and movement control in humans. We developed a unique model system to examine the role of α4-nAChRs within dopaminergic neurons by a targeted genetic deletion of the α4 subunit from dopaminergic neurons in mice. The loss α4 mRNA and α4β2-nAChRs from dopaminergic neurons was confirmed, as well as selective loss of α4β2-nAChR function from dopaminergic but not GABAergic neurons. Two behaviors central to nicotine dependence, reward and anxiety relief, were examined. α4-nAChRs specifically on dopaminergic neurons were demonstrated to be necessary for nicotine reward as measured by nicotine place preference, but not for another drug of addiction, cocaine. α4-nAChRs are necessary for the anxiolytic effects of nicotine in the elevated plus maze, and elimination of α4β2-nAChRs specifically from dopaminergic neurons decreased sensitivity to the anxiolytic effects of nicotine. Deletion of α4-nAChRs specifically from dopaminergic neurons also increased sensitivity to nicotine-induced locomotor depression; however, nicotine-induced hypothermia was unaffected. This is the first work to develop a dopaminergic specific deletion of a nAChR subunit and examine resulting changes in nicotine-related behaviors.

Indexed as

RewardAnalysis of VarianceAnimalsAnxietyBehavior, AnimalBody TemperatureBridged Bicyclo Compounds, HeterocyclicConditioning, OperantDisease Models, AnimalDopamineDopamine Plasma Membrane Transport ProteinsFemalegamma-Aminobutyric AcidGlutamate DecarboxylaseMaleMesencephalonBridged Bicyclo Compounds, HeterocyclicDopamineDopamine Plasma Membrane Transport Proteinsepibatidinegamma-Aminobutyric AcidGlutamate Decarboxylaseglutamate decarboxylase 1NicotineNicotinic Agonistsnicotinic receptor alpha4beta2PyridinesReceptors, NicotinicTritium

Identifiers

PMID21795541
PMCPMC3539812
OpenAlexW1973295491

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.